- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Varian strikes supply agreements in oncology
HealthTrust Purchasing Group and Varian Medical Systems have renewed and expanded a three-year agreement to supply HealthTrust members with advanced systems for treating cancer with radiotherapy through the year 2003. Mid Atlantic Group Network of Shared
HealthTrust Purchasing Group and Varian Medical Systems have renewed and expanded a three-year agreement to supply HealthTrust members with advanced systems for treating cancer with radiotherapy through the year 2003. Mid Atlantic Group Network of Shared Services (MAGNET) has also renewed a preferred pricing agreement for Varian to supply members with radiotherapy equipment. The contracts cover a range of equipment including Ximatron treatment simulators, linear accelerators, and SmartBeam IMRT (intensity-modulated radiation therapy), a highly precise radiation therapy technology.
HealthTrust is one of the nation's largest healthcare group purchasing organizations with a current membership of more than 600 facilities. Members of MAGNET, one of the oldest, largest, and most experienced shared service/GPOs in the U.S., serve over 775 hospitals and 1100 nursing homes, along with more than 5000 physicians and 1000 allied healthcare organizations in 20 states.
© 2001 Miller Freeman Inc.
3/28/01, Issue # 1506, page 6.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
